Severe pertussis and hyperleukocytosis: is it time to change for exchange?

Amir Kuperman1, Yoav Hoffmann, Danny Glikman

  • 1Pediatric Hematology Clinic and Coagulation Service, Western Galilee Hospital, Naharia, Israel; Faculty of Medicine in the Galilee, Bar-Ilan University, Safed, Israel.

Transfusion
|December 17, 2013
PubMed

Insights

Exchange transfusion (ET) is a critical treatment for severe pertussis (whooping cough) with hyperleukocytosis in infants. This case report suggests ET can lead to recovery without lasting effects, highlighting its importance in managing this severe condition.

Area of Science:

  • Pediatrics
  • Infectious Diseases
  • Hematology

Background:

  • Pertussis remains a significant global cause of infant mortality, posing a public health challenge.
  • Severe pertussis, characterized by hyperleukocytosis, carries an extremely high mortality rate (up to 80%).
  • Previous studies on exchange transfusion (ET) for reducing white blood cell burden in critical pertussis have yielded conflicting results.

Observation:

  • This report details a case of critical pertussis with hyperleukocytosis in a neonate.
  • The neonate underwent exchange transfusion (ET) as a therapeutic intervention.
  • A comprehensive literature review was conducted in conjunction with the case management.

Findings:

  • The neonate treated with ET experienced a full recovery.
  • The patient was discharged from the hospital without any long-term sequelae.
  • This outcome suggests the efficacy of ET in managing severe pertussis.

Implications:

  • Exchange transfusion (ET) should be strongly considered for all infants diagnosed with critical pertussis and hyperleukocytosis.
  • The consideration of ET is warranted even in secondary care community hospital settings.
  • This approach may improve outcomes for infants with this life-threatening condition.
Abstract

Related Concept Videos

Transmission-based Precautions II: Airborne and Protective Environment01:25

Transmission-based Precautions II: Airborne and Protective Environment

Transmission-based precautions are for patients infected or suspected to be infected (or colonized) with organisms posing a significant risk to others. The transmission precautions include airborne and protective environment precautions.
Airborne precautions:
Use airborne precautions when treating patients known or suspected to have diseases that spread through the air—for example, tuberculosis or measles. These organisms are present in smaller droplets expelled by an infected person and...
2.0K
Disorders of Leukocytes01:27

Disorders of Leukocytes

Leukocyte disorders can lead to either leukopenia, characterized by an abnormally low leukocyte count, or leukocytosis, marked by a very high leukocyte number.
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune...
2.3K
Transmission-based Precautions I: Contact, Enteric, and Droplets01:17

Transmission-based Precautions I: Contact, Enteric, and Droplets

Transmission-based precautions are for patients known to be infected or suspected to be infected or colonized with organisms that pose a significant risk to others. Some transmission-based precautions include contact, enteric, and droplet.
Contact Precautions:
Contact precautions are the measures taken to prevent the transmission of infectious agents, especially epidemiologically important microorganisms such as MRSA or influenza, primarily transmitted through direct or indirect contact with an...
5.0K
Chronic Pharyngitis01:23

Chronic Pharyngitis

Chronic pharyngitis refers to persistent inflammation of the pharyngial mucosa.
Etiology
It often arises from persistent viral or bacterial infections affecting sinuses and tonsils.
Additional contributing factors include inadequate dental hygiene, mouth breathing, recurring tonsillitis, allergic rhinitis, laryngopharyngeal reflux, and exposure to smoke, chemicals, and other environmental pollutants. Allergic reactions to pollen, mold, and pet dander, chronic cough, excessive voice usage,...
16.7K
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
1.4K
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features01:24

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features

Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
40